Welcome
Support Centre
08 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A Study of the Prevention of Alloimmunisation using Leukocyte-Depleted Red Cell and Platelet Donations
ISRCTN ISRCTN43344383
ClinicalTrials.gov identifier
Public title A Study of the Prevention of Alloimmunisation using Leukocyte-Depleted Red Cell and Platelet Donations
Scientific title
Acronym N/A
Serial number at source LK/FIL
Study hypothesis Not provided at time of registration
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Leukaemia (acute), Leukaemia (chronic)
Participants - inclusion criteria 1. Patients with acute leukaemia, chronic myeloid leukaemia, severe aplastic anaemia or high grade lymphoma
2. Patients already known to have Human Leukocyte Antigens (HLA) antibodies or recurrent febrile transfusion reactions are ineligible
3. Any age
4. Fit to undergo the treatments as defined in protocol
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/1990
Anticipated end date 01/04/1992
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions 1. Arm A: Patients receive standard non-filtered, non-leukocyte-depleted blood products
2. Arm B: Patients receive Pall filtered blood or platelet donations
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Pall Biomedical Ltd (UK)
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 207 670 4723
  Fax +44 (0) 207 670 4818
  Email
Sponsor Pall Biomedical Ltd (UK)
  Address Europa House
Havant Street
  City/town Portsmouth
  Zip/Postcode PO1 3PD
  Country United Kingdom
  Sponsor website: http://www.pall.com/
Date applied 19/08/2002
Last edited 05/01/2011
Date ISRCTN assigned 19/08/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central